Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating activities:
Net loss	$ (60,117)	$ (22,858)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	7,960	9,300
Equity-based compensation cost	9,114	1,649
Gain on disposal of property and equipment	(315)	(71)
Provision for doubtful accounts	19,120	0
Amortization of loan issuance costs and debt discounts	4,115	14,886
Payment in kind interest	0	4,848
Unrealized loss (gain) on foreign currency transactions	2,420	(1,094)
Gain on debt extinguishment	(53)	0
Changes in operating assets and liabilities:
Accounts receivable	(4,663)	16,269
Prepaid expenses and other current assets	1,800	(2,096)
Deferred costs on contracts	1,659	8,444
Accounts payable	1,020	(6,593)
Accrued liabilities	519	(4,409)
Income and other taxes payable	(2,298)	(5,218)
Deferred revenue	(2,296)	(7,975)
Other, net	(49)	62
Net cash (used in) provided by operating activities	(22,064)	5,144
Cash flows from investing activities:
Asset purchase	(21,749)	0
Purchase of property and equipment	(1,044)	(2,348)
Proceeds from sale of property and equipment	657	1,965
Net cash used in investing activities	(22,136)	(383)
Cash flows from financing activities:
Long-term debt repayments	(56,271)	(35,166)
Long-term debt borrowings	123,411	33,401
Capital lease repayments	0	(56)
Debt issuance costs	(1,602)	0
Stock issuance costs	(2,179)	0
Purchase of treasury stock	(1,753)	(113)
Distribution to noncontrolling interest	(500)	(1,095)
Net cash provided by (used in) financing activities	61,106	(3,029)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(219)	344
Net change in cash, cash equivalents and restricted cash	16,687	2,076
Cash, cash equivalents and restricted cash at the beginning of period	3,654	11,996
Cash, cash equivalents and restricted cash at the end of period	$ 20,341	$ 14,072